Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder

Journal of Affective Disorders

Volumn 125, Issue 1-3, 2010, Pages 341-344

  Benedetti, Francesco ^a   Dallaspezia, Sara ^a   Colombo, Cristina ^a   Lorenzi, Cristina ^a   Pirovano, Adele ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bipolar disorder; COMT; Delusion; Dopamine; Psychosis

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; COMT GENE; CONTROLLED STUDY; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; PSYCHOSIS; STATISTICAL SIGNIFICANCE;

ADULT; ALLELES; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; DELUSIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HALLUCINATIONS; HOMOZYGOTE; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 77955559765     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.01.005     Document Type: Article

References (32)

1. M. Akil, B.S. Kolachana, D.A. Rothmond, T.M. Hyde, D.R. Weinberger, and J.E. Kleinman Catechol-O-methyltransferase genotype and dopamine regulation in the human brain J. Neurosci. 23 2003 2008 2013
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th Edition 1994 American Psychiatric Association Washington DC
3. N. Basterreche, R. Davila, M. Zumarraga, A. Arrue, M.A. Gonzalez-Torres, M.I. Zamalloa, J.B. Anguiano, and J. Guimon Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder Neuropsychobiology 58 2008 111 117
4. F. Benedetti, B. Barbini, A. Bernasconi, M.C. Fulgosi, S. Dallaspezia, C. Gavinelli, C. Locatelli, C. Lorenzi, A. Pirovano, D. Radaelli, E. Smeraldi, and C. Colombo Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism J. Affect Disord. 121 1-2 2009 68 72
5. F. Benedetti, C. Colombo, A. Pirovano, E. Marino, and E. Smeraldi The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting Psychopharmacology (Berl) 203 2009 155 160
6. F. Benedetti, C. Colombo, A. Pirovano, E. Marino, and E. Smeraldi The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting Psychopharmacology (Berl) 203 2009 155 160
7. D.B. Carr, and S.R. Sesack Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons J. Neurosci. 20 2000 3864 3873
8. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, S. Melhem, B.S. Kolachana, T.M. Hyde, M.M. Herman, J. Apud, M.F. Egan, J.E. Kleinman, and D.R. Weinberger Functional analysis of genetic variation in catechol-O- methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain Am. J. Hum. Genet 75 2004 807 821
9. R. Davila, M. Zumarraga, N. Basterreche, A. Arrue, M.I. Zamalloa, and J.B. Anguiano Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder-a preliminary report J. Affect Disord. 92 2006 277 281
10. A.Y. Deutch Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease J. Neural. Transm. Gen. Sect. 91 1993 197 221
11. M.F. Egan, T.E. Goldberg, B.S. Kolachana, J.H. Callicott, C.M. Mazzanti, R.E. Straub, D. Goldman, and D.R. Weinberger Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc. Natl. Acad. Sci. U. S. A. 98 2001 6917 6922
12. V.M. Goghari, and S.R. Sponheim Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder Schizophr. Res. 103 2008 186 191
13. A.A. Grace Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res. Brain Res. Rev. 31 2000 330 341
14. R.E. Gur, M.S. Keshavan, and S.M. Lawrie Deconstructing psychosis with human brain imaging Schizophr. Bull. 33 2007 921 931
15. D.H. Han, B.S. Kee, K.J. Min, Y.S. Lee, C. Na, D.B. Park, and I.K. Lyoo Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients Neuroreport 17 2006 95 99
16. H. Herken, and M.E. Erdal Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis Psychiatr. Genet. 11 2001 105 109
17. P.E. Keck Jr., S.L. McElroy, J.R. Havens, L.L. Altshuler, W.A. Nolen, M.A. Frye, T. Suppes, K.D. Denicoff, R. Kupka, G.S. Leverich, A.J. Rush, and R.M. Post Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness Compr. Psychiatry 44 2003 263 269
18. H. Kunugi, H.P. Vallada, F. Hoda, G. Kirov, M. Gill, K.J. Aitchison, D. Ball, M.J. Arranz, R.M. Murray, and D.A. Collier No evidence for an association of affective disorders with high-or low-activity allele of catechol-O- methyltransferase gene Biol. Psychiatry 42 1997 282 285
19. H.M. Lachman Does COMT val158met affect behavioral phenotypes: yes, no, maybe? Neuropsychopharmacology 33 2008 3027 3029
20. J.F. Leckman, D. Sholomskas, W.D. Thompson, A. Belanger, and M.M. Weissman Best estimate of lifetime psychiatric diagnosis: a methodological study Arch. Gen Psychiatry 39 1982 879 883
21. P. Molero, F. Ortuno, M. Zalacain, and A. Patino-Garcia Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment Pharmacogenomics J. 7 2007 418 426
22. G. Salvadore, W.C. Drevets, I.D. Henter, C.A. Zarate, and H.K. Manji Early intervention in bipolar disorder, Part II: therapeutics Early Interv. Psychiatry 2 2008 136 146
23. J.B. Savitz, L. van der Merwe, T.K. Newman, M. Solms, D.J. Stein, and R.S. Ramesar The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity? Int. J. Neuropsychopharmacol. 11 2008 149 161
24. A. Serretti, A. Rotondo, C. Lorenzi, E. Smeraldi, and G. Cassano Catechol-O-methyltransferase gene variants in mood disorders in the Italian population Psychiatr. Genet. 16 2006 181 182
25. A.L. Silberschmidt, and S.R. Sponheim Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism Schizophr. Res. 100 2008 316 324
26. C.J. Simons, M. Wichers, C. Derom, E. Thiery, I. Myin-Germeys, L. Krabbendam, and J. van Os Subtle gene-environment interactions driving paranoia in daily life Genes Brain Behav. 8 2009 5 12
27. N.C. Stefanis, C. Henquet, D. Avramopoulos, N. Smyrnis, I. Evdokimidis, I. Myin-Germeys, C.N. Stefanis, and J. Van Os COMT Val158Met moderation of stress-induced psychosis Psychol. Med. 37 2007 1651 1656
28. R.D. Strous, R. Lapidus, D. Viglin, M. Kotler, and H.M. Lachman Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia Neurosci. Lett. 393 2006 170 173
29. S.J. Tsai, Y.T. Gau, C.J. Hong, Y.J. Liou, Y.W. Yu, and C. TJ Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients J. Affect. Disord. 113 2008 183 187
30. S.J. Tsai, C.J. Hong, D.L. Liao, I.C. Lai, and Y.J. Liou Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia Neuropsychobiology 49 2004 196 200
31. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch. Gen. Psychiatry 44 1987 660 669
32. K. Yoshida, H. Higuchi, H. Takahashi, M. Kamata, K. Sato, K. Inoue, T. Suzuki, K. Itoh, and N. Ozaki Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran Hum. Psychopharmacol. 23 2008 121 128